Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Shares Issued (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Shares Issued for 5 consecutive years, with $30000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $30000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $131.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $65000.0 for FY2025, 36.89% down from the prior year.
  • Shares Issued hit $30000.0 in Q4 2025 for Kezar Life Sciences, down from $131.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $131.7 million in Q2 2023 to a low of $30000.0 in Q4 2025.
  • Historically, Shares Issued has averaged $34.0 million across 5 years, with a median of $394000.0 in 2021.
  • Biggest YoY gain for Shares Issued was 27524.11% in 2022; the steepest drop was 84.05% in 2022.
  • Year by year, Shares Issued stood at $580000.0 in 2021, then decreased by 12.76% to $506000.0 in 2022, then soared by 25927.67% to $131.7 million in 2023, then changed by 0.0% to $131.7 million in 2024, then plummeted by 99.98% to $30000.0 in 2025.
  • Business Quant data shows Shares Issued for KZR at $30000.0 in Q4 2025, $131.7 million in Q2 2024, and $131.7 million in Q4 2023.